In tissue array studies, enhanced S1PR1 co-localising with STAT3 was commonly seen in higher-grade GC tumours; GC patients with high S1PR1-STAT3 expression responded poorly to chemotherapy drugs and blocking S1PR1-STAT3 signalling re-sensitised drug resistance in GC cells [131]. The gene discussed is STAT3; the disease is gastric cancer.